Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxybutynin versus venlafaxine for menopausal hot flushes in women not using HRT
ISRCTN32277407Phase 4Active, not recruiting
- Sponsor
- University College London
- Start
- Apr 2025
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial in vasomotor symptoms and hot flash comparing Oxybutynin with Venlafaxine (2 arms). Primary endpoint: Average hot flush score over one week at week 12. Started Apr 2025; status: active, not recruiting.
02
Drugs
oxybutyninvenlafaxine
03
Conditions
vasomotor symptomshot flash
Beyond the preview
Go deeper on ISRCTN32277407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN32277407.